Asahi Kasei Pharma has announced the new application period for their annual “Open Innovation” solicitation of proposals for drug discovery research. Through collaboration with universities, research institutes, and companies around the world, Asahi Kasei Pharma has been supporting innovation in drug discovery since 2018 and will fund up to $200,000 US per year for each selected proposal of the upcoming round in 2023.
With “Global Specialty Pharma” highlighted as one of the 10 Growth Gears in our 2024 Medium-term Management Plan, endeavors like this for discovering new drugs for conditions with unmet needs will play a key role for growth in our Health Care Sector in the long term. We look forward to supporting drug discovery research as Trailblazers in the pharmaceuticals industry.
Read the full press release below.
Learn more about research areas/subjects and how to apply at the Asahi Kasei Pharma Open Innovation homepage.
Media Inquiries North America
ATTN: Jonathan Todd
Asahi Kasei America, Inc.
Media Inquiries Europe
ATTN: Sebastian Schmidt
Asahi Kasei Europe GmbH